{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:24:41Z","timestamp":1794255881528,"version":"4.9.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Sun Pharmaceutical Industries Limited"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12325-026-03722-0","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:38:02Z","timestamp":1785911882000},"page":"5416-5429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Outcomes with High-Dose Amoxycillin\u2013Clavulanate Suspension in Children with Respiratory Tract Infections: A Prospective, Multicentre, Phase IV Study in India"],"prefix":"10.1007","volume":"43","author":[{"given":"Rajib","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashil Dilipbhai","family":"Manavadaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monjori","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Wari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikkalingaiah","family":"Siddegowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suma Priya","family":"Molugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. V.","family":"Prashanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurva","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5481-7780","authenticated-orcid":false,"given":"Supriya","family":"Sonowal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sucheta","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipak","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Puppalwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Ghadge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyog","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"issue":"12","key":"3722_CR1","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.3390\/pathogens10121596","volume":"10","author":"T Tenenbaum","year":"2021","unstructured":"Tenenbaum T. Respiratory tract infections in children. Pathogens (Basel). 2021;10(12):1596. https:\/\/doi.org\/10.3390\/pathogens10121596.","journal-title":"Pathogens (Basel)"},{"key":"3722_CR2","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.26655\/JMCHEMSCI.2024.12.7","volume":"7","author":"NS Albishi","year":"2024","unstructured":"Albishi NS, Alenazi AO, Alshammari WO, et al. Respiratory infections in children: an updated review of pathophysiology, diagnosis, treatment, biochemical aspects, and nursing interventions. J Med Chem Sci. 2024;7:1847\u201360. https:\/\/doi.org\/10.26655\/JMCHEMSCI.2024.12.7.","journal-title":"J Med Chem Sci"},{"issue":"1","key":"3722_CR3","doi-asserted-by":"publisher","first-page":"04","DOI":"10.33545\/26646676.2025.v7.i1a.11","volume":"7","author":"AEA Osman","year":"2025","unstructured":"Osman AEA. Excessive antibiotic use in respiratory infections: potential interventions. Int J Pulm Respir Res. 2025;7(1):04\u20139. https:\/\/doi.org\/10.33545\/26646676.2025.v7.i1a.11.","journal-title":"Int J Pulm Respir Res"},{"key":"3722_CR4","unstructured":"World Health Organization. Pneumonia in children. Updated November 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/pneumonia. Accessed 06 Dec 2025."},{"issue":"9","key":"3722_CR5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/s2352-4642(20)30238-8","volume":"4","author":"A Pandey","year":"2020","unstructured":"Pandey A, Galvani AP. The burden of childhood pneumonia in India and prospects for control. Lancet Child Adolesc Health. 2020;4(9):643\u20135. https:\/\/doi.org\/10.1016\/s2352-4642(20)30238-8.","journal-title":"Lancet Child Adolesc Health"},{"issue":"8","key":"3722_CR6","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.ijporl.2006.01.013","volume":"70","author":"J Nokso-Koivisto","year":"2006","unstructured":"Nokso-Koivisto J, Hovi T, Pitk\u00e4ranta A. Viral upper respiratory tract infections in young children with emphasis on acute otitis media. Int J Pediatr Otorhinolaryngol. 2006;70(8):1333\u201342. https:\/\/doi.org\/10.1016\/j.ijporl.2006.01.013.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"3722_CR7","unstructured":"Evans J,\u00a0Hanoodi M,\u00a0Wittler M. Amoxicillin clavulanate. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Updated August 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538164\/. Accessed 06 Dec 2025."},{"key":"3722_CR8","unstructured":"Government of India. National Action Plan on Antimicrobial Resistance (NAP-AMR) (2025\u20132029) One Health Approach. 2025. https:\/\/www.ncdc.mohfw.gov.in\/uploads\/pdf\/amr10.pdf. Accessed 06 Dec 2025."},{"key":"3722_CR9","unstructured":"Institute of Health Metrics and Evaluation. The burden of antimicrobial resistance (AMR) in India. 2023. https:\/\/www.healthdata.org\/sites\/default\/files\/2023-09\/India.pdf. Accessed 06 Dec 2025."},{"issue":"10","key":"3722_CR10","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1128\/aac.47.10.3179-3186.2003","volume":"47","author":"A Arrieta","year":"2003","unstructured":"Arrieta A, Arguedas A, Fernandez P, et al. High-dose azithromycin versus high-dose amoxicillin\u2013clavulanate for treatment of children with recurrent or persistent acute otitis media. Antimicrob Agents Chemother. 2003;47(10):3179\u201386. https:\/\/doi.org\/10.1128\/aac.47.10.3179-3186.2003.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3722_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3126\/ajms.v12i4.33541","volume":"12","author":"S Lahiry","year":"2021","unstructured":"Lahiry S, Dalal K, Pawar A, Kotak B. High-dose amoxicillin supported with clavulanic acid as empirical therapy in acute otitis media. Asian J Med Sci. 2021;12(4):134\u201344. https:\/\/doi.org\/10.3126\/ajms.v12i4.33541.","journal-title":"Asian J Med Sci"},{"key":"3722_CR12","doi-asserted-by":"publisher","first-page":"e939258","DOI":"10.12659\/AOT.939258","volume":"28","author":"P Wilkowski","year":"2023","unstructured":"Wilkowski P, Hryniewiecka E, Jasi\u0144ska K, P\u0105czek L, Ciszek M. Breaking antimicrobial resistance: high-dose amoxicillin with clavulanic acid for urinary tract infections due to extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae. Ann Transplant. 2023;28:e939258. https:\/\/doi.org\/10.12659\/AOT.939258.","journal-title":"Ann Transplant"},{"key":"3722_CR13","unstructured":"Ministry of Health and Family Welfare. National Treatment Guidelines for Antimicrobial Use in Infectious Diseases. 2016. https:\/\/ncdc.mohfw.gov.in\/uploads\/resource\/1769332642_File622.pdf. Accessed 06 Dec 2025."},{"key":"3722_CR14","unstructured":"Akhavan BJ,\u00a0Khanna NR,\u00a0Vijhani P. Amoxicillin. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Updated November 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482250\/. Accessed 06 Dec 2025."},{"issue":"7","key":"3722_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cmi.2019.11.028","volume":"26","author":"A Huttner","year":"2020","unstructured":"Huttner A, Bielicki J, Clements MN, et al. Oral amoxicillin and amoxicillin\u2013clavulanic acid: properties, indications and usage. Clin Microbiol Infect. 2020;26(7):871\u20139. https:\/\/doi.org\/10.1016\/j.cmi.2019.11.028.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"3722_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40121-020-00374-7","volume":"10","author":"B Veeraraghavan","year":"2021","unstructured":"Veeraraghavan B, Bakthavatchalam YD, Sahni RD. Orally administered amoxicillin\/clavulanate: current role in outpatient therapy. Infect Dis Ther. 2021;10(1):15\u201325. https:\/\/doi.org\/10.1007\/s40121-020-00374-7.","journal-title":"Infect Dis Ther"},{"key":"3722_CR17","unstructured":"Indian Academy of Pediatrics (IAP). Standard Treatment Guidelines 2022. Acute Otitis Media. 2022. https:\/\/iapindia.org\/pdf\/Ch-023-STG-Acute-Otitis-Media.pdf. Accessed 06 Dec 2025."},{"key":"3722_CR18","unstructured":"Indian Academy of Pediatrics (IAP). Standard Treatment Guidelines 2022. Community-Acquired Pneumonia. 2022. https:\/\/iapindia.org\/pdf\/Ch-011-Community-Acquired-Pneumonia.pdf. Accessed 06 Dec 2025."},{"key":"3722_CR19","unstructured":"Ministry of Health and Family Welfare. National Health Mission. Standard treatment guidelines on acute sinusitis. https:\/\/qps.nhsrcindia.org\/sites\/default\/files\/2021-05\/Management%20Of%20Sinusitis%20In%20Adults.pdf. Accessed 06 Dec 2025."},{"key":"3722_CR20","unstructured":"Uto LR,\u00a0Gerriets V. Clavulanic acid. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Updated May 2023. https:\/\/www.ncbi.nlm.nih.gov\/sites\/books\/NBK545273\/. Accessed 06 Dec 2025."},{"key":"3722_CR21","unstructured":"ClinicalTrials.gov. Study to Evaluate the Safety and Clinical Efficacy of Augmentin\u00ae Extra Strength-600 in Children With Acute Otitis Media in India. Updated Jun 2024. https:\/\/www.clinicaltrials.gov\/study\/NCT04600752. Accessed 06 Dec 2025."},{"key":"3722_CR22","unstructured":"Puckett L. Guide to Amoxicillin\u2013clavulanate (Augmentin\u00ae) Dosing. Updated 2025. https:\/\/www.stanfordchildrens.org\/content-public\/pdf\/antimicrobial-stewardship-program\/augmentin-dosing-guide.pdf. Accessed 06 Dec 2025."},{"key":"3722_CR23","unstructured":"World Health Organization. The WHO AWaRe (Access, Watch, Reserve) antibiotic book. 2022. https:\/\/www.who.int\/publications\/b\/61917. Accessed 06 Dec 2025."},{"issue":"7","key":"3722_CR24","doi-asserted-by":"publisher","first-page":"916","DOI":"10.18203\/2349-3291.ijcp20241676","volume":"11","author":"S Manjula","year":"2024","unstructured":"Manjula S, Krishna Kumar M. Expert perspectives on the clinical use of high-dose amoxicillin with clavulanic acid in pediatric practice in Indian settings. Int J Contemp Pediatr. 2024;11(7):916\u201320. https:\/\/doi.org\/10.18203\/2349-3291.ijcp20241676.","journal-title":"Int J Contemp Pediatr"},{"key":"3722_CR25","unstructured":"Aidarex Pharmaceuticals LLC. Amoxicillin and clavulanate potassium for oral suspension USP, 600 mg\/42.9 mg per 5 mL. Updated November 2016. https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=85f3972f-205e-4de6-b8ce-aa93cd1a0e2e. Accessed 06 Dec 2025."},{"key":"3722_CR26","unstructured":"World Health Organization. Antimicrobial resistance. Updated November 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance. Accessed 19 Jan 2026."},{"issue":"11","key":"3722_CR27","doi-asserted-by":"publisher","first-page":"e0224848","DOI":"10.1371\/journal.pone.0224848","volume":"14","author":"HH Farooqui","year":"2019","unstructured":"Farooqui HH, Mehta A, Selvaraj S. Outpatient antibiotic prescription rate and pattern in the private sector in India: evidence from medical audit data. PLoS ONE. 2019;14(11):e0224848. https:\/\/doi.org\/10.1371\/journal.pone.0224848.","journal-title":"PLoS ONE"},{"key":"3722_CR28","unstructured":"Indian Council of Medical Research. Updated 2019. https:\/\/iamrsn.icmr.org.in\/images\/pdf\/Treatment_guidelines_2019.pdf. Accessed 29 Jun 2026."},{"issue":"6","key":"3722_CR29","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/01.inf.0000164794.50281.1a","volume":"24","author":"A Hoberman","year":"2005","unstructured":"Hoberman A, Dagan R, Leibovitz E, et al. Large dosage amoxicillin\/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children. Pediatr Infect Dis J. 2005;24(6):525\u201332. https:\/\/doi.org\/10.1097\/01.inf.0000164794.50281.1a.","journal-title":"Pediatr Infect Dis J"},{"key":"3722_CR30","doi-asserted-by":"publisher","first-page":"965096","DOI":"10.1155\/2014\/965096","volume":"2013","author":"CH Chu","year":"2014","unstructured":"Chu CH, Wang MC, Lin LY, et al. High-dose amoxicillin with clavulanate for the treatment of acute otitis media in children. ScientificWorldJournal. 2014;2013:965096. https:\/\/doi.org\/10.1155\/2014\/965096.","journal-title":"ScientificWorldJournal"},{"issue":"1","key":"3722_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1542\/peds.2008-2902","volume":"124","author":"ER Wald","year":"2009","unstructured":"Wald ER, Nash D, Eickhoff J. Effectiveness of amoxicillin\/clavulanate potassium in the treatment of acute bacterial sinusitis in children. Pediatrics. 2009;124(1):9\u201315. https:\/\/doi.org\/10.1542\/peds.2008-2902.","journal-title":"Pediatrics"},{"issue":"8","key":"3722_CR32","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1093\/cid\/cir1043","volume":"54","author":"AW Chow","year":"2012","unstructured":"Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012;54(8):e72\u2013112. https:\/\/doi.org\/10.1093\/cid\/cir1043.","journal-title":"Clin Infect Dis"},{"issue":"2 Suppl","key":"3722_CR33","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599815572097","volume":"152","author":"RM Rosenfeld","year":"2015","unstructured":"Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(2 Suppl):S1\u201339. https:\/\/doi.org\/10.1177\/0194599815572097.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"9","key":"3722_CR34","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/00006454-200109000-00002","volume":"20","author":"R Dagan","year":"2001","unstructured":"Dagan R, Hoberman A, Johnson C, et al. Bacteriologic and clinical efficacy of high dose amoxicillin\/clavulanate in children with acute otitis media. Pediatr Infect Dis J. 2001;20(9):829\u201337. https:\/\/doi.org\/10.1097\/00006454-200109000-00002.","journal-title":"Pediatr Infect Dis J"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03722-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03722-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03722-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:03:10Z","timestamp":1794254590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03722-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3722"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03722-0","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"9 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Rajib Ray, Ashil Dilipbhai Manavadaria, Monjori Mitra, Saurabh Gandhi, Neeraj Yadav, Prakash Wari, Richa Giri, Chikkalingaiah Siddegowda, Suma Priya Molugu, Jitendra Shukla, M. V. Prashanth, and Sandeep Kumar Gupta were study investigators and received funding for the conduct of the study. Shruti Saha, Supriya Sonowal,\u00a0Sucheta Pandit, Dipak Patil, Gaurav Puppalwar, Pravin Ghadge and Suyog Mehta are full-time employees of Sun Pharma Laboratories Limited. Apurva Shetty was a full-time employee of Sun Pharma Laboratories Limited during the conduct of the study.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by institutional ethics committees at each study site prior to study initiation. Written informed consent was obtained from the parents\/legal guardians of all enrolled patients prior to participation in the study. In addition, age-appropriate assent was obtained from children in accordance with applicable regulatory guidelines and protocol requirements. Before the screening procedures, patients and their parents\/legal guardians were provided with detailed information about the study objectives, procedures, and the fixed-dose combination of amoxycillin and potassium clavulanate oral suspension (600\u00a0mg\u2009+\u200942.9\u00a0mg\/5\u00a0mL) to be administered during the study. Consent and assent, where applicable, were documented before any study-related activities commenced. Good Clinical Practice guidelines, local applicable regulations and the Declaration of Helsinki (2013) were followed. Furthermore, this study conformed to all regulations concerning the use of personal data.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}